<DOC>
	<DOCNO>NCT01030094</DOCNO>
	<brief_summary>The purpose study investigate influence topiramate monotherapy bone mineral metabolism marker , bone density ( amount mineral per square centimeter bone ) female participant epilepsy ( seizure disorder ) , menopause ( time life woman stop menstrual period ) , compare healthy participant comparative group receive either carbamazepine valproic acid monotherapy least last one year .</brief_summary>
	<brief_title>A Cross-sectional Study Investigate Effect Topiramate Bone Mineral Metabolism Female Participants With Epilepsy</brief_title>
	<detailed_description>This cross-sectional ( observation measurement make single point time , usually participant enrollment ) , multi-center ( conducted one center ) , comparative study topiramate monotherapy female participant epilepsy . Female participant must receive either topiramate , carbamazepine , valproic acid monotherapy one year treatment epilepsy . Blood sample obtain fast participant investigate effect study drug bone mineral metabolism marker , bone density compare healthy participant comparative group ( carbamazepine valproic acid monotherapy ) . Bone mineral density measure participant ' lumbar spine femur . A survey food intake physical activity participant perform use standardize validate detailed questionnaire . The post-study visit ( follow phone contact ) perform occurrence serious adverse event ( SAE ) safety evaluation . Participants ' safety monitor throughout study .</detailed_description>
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Bone Diseases , Metabolic</mesh_term>
	<mesh_term>Topiramate</mesh_term>
	<mesh_term>Valproic Acid</mesh_term>
	<mesh_term>Carbamazepine</mesh_term>
	<criteria>Participants agree participate study Female epileptic participant Participants receive topiramate , carbamazepine valproic acid monotherapy one year Participants use proper contraceptive method ( ) negative pregnancy test result Participants motor function disorder Participants disease affect skeleton include primary hyperparathyroidism , Paget 's disease , multiple myeloma , liver kidney disorder , thyroid disease , malabsorption disorder , diabetes , malignancy Participants take within last one year , currently take drug affect bone mineral metabolism vitamin D , calcium , anabolic steroid , bisphosphonates , calcitonin , glucocorticoid , diuretic Voluntary surgical postmenopausal participant Participants amenorrhea 6 month</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Topiramate</keyword>
	<keyword>Carbamazepine</keyword>
	<keyword>Valproic acid</keyword>
	<keyword>Epilepsy</keyword>
	<keyword>Bone mineral density</keyword>
	<keyword>Monotherapy</keyword>
</DOC>